Skip to main content

Revolution Medicines, Inc.

RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesRVMDW

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Revolution Medicines, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
17 filings
9 insiders, $76.7M in total
Insiders trading
9
Net value
−$76.7M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Revolution Medicines, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Revolution Medicines, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cislini JeffSVP & General Counsel51,776Sep 29, 202610
Mancini AnthonySee Remarks39,765Sep 28, 20268
Anderson Elizabeth MDirector4,333Sep 24, 20263
Sandler Alan B.Chief Development Officer52,868Sep 18, 20261
Kelsey Stephen MichaelSee Remarks286,307Sep 18, 20267
Horn Margaret AChief Operating Officer149,680Sep 18, 20267
Goldsmith Mark ASee Remarks253,342Sep 18, 202613
Anders JackChief Financial Officer119,216Sep 18, 20269
Kim Lorence H.Director0IndirectSep 10, 20263
Patel SushilDirector21,656Jul 1, 20262
Borisy AlexisDirector2,340,075Jun 23, 20261
Horning SandraDirector97,765Jun 23, 20261
Clyburn FrankDirector10,929Jun 23, 20261
Borellini FlaviaDirector26,215Jun 23, 20261
Wang XiaolinSee Remarks116,063Mar 19, 20262
Wei LinChief Medical Officer101,366Mar 19, 20262
Schroeder ThiloDirector760,869IndirectDec 9, 20240
Weber BarbaraDirector13,065Oct 10, 20240
Schmidt Eric ThomasDirector21,251Jun 12, 20230
Exter NeilDirector28,815Jun 17, 20220
Tepper Robert I10% Owner5,104,130Jun 10, 20220
Third Rock Ventures III, L.P.10% Owner5,104,130Jun 10, 20220
TRV GP III, LLC10% Owner5,104,130Jun 10, 20220
Third Rock Ventures GP III, L.P.10% Owner5,104,130Jun 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 20, 2023 (view filing)Sep 182 daysGoldsmith Mark ASee RemarksSSale−8.05K$31.31−$252.2K−2.3%349.3K after
Sep 20, 2023 (view filing)Sep 182 daysCislini JeffGeneral CounselSSale−1.21K$31.31−$38.0K−2.8%42.0K after
Sep 20, 2023 (view filing)Sep 182 daysAnders JackChief Financial OfficerSSale−1.43K$31.31−$44.7K−2.6%53.7K after
Sep 19, 2023 (view filing)Sep 15-184 daysHorn Margaret AChief Operating OfficerSSale−7.51K$31.82−$239.1K−7.2%97.0K after2 lots10b5-1
Sep 6, 2023 (view filing)Sep 15 daysGoldsmith Mark ASee RemarksSSale−30.0K$35.05−$1.05M−7.7%357.4K after
Sep 6, 2023 (view filing)Sep 15 daysGoldsmith Mark ASee RemarksSSale−10.0K$35.04−$350.4K−22.0%35.4K after2 lots
Sep 6, 2023 (view filing)Sep 15 daysWeber BarbaraDirectorSSale−15.0K$35.07−$526.0K−48.7%15.8K after
Sep 6, 2023 (view filing)Sep 15 daysAnders JackChief Financial OfficerSSale−20.0K$35.05−$701.0K−26.6%55.1K after10b5-1
Sep 1, 2023 (view filing)Aug 311 dayHorn Margaret AChief Operating OfficerSSale−10.0K$34.05−$340.5K−9.1%99.5K after10b5-1
Aug 17, 2023 (view filing)Aug 152 daysHorn Margaret AChief Operating OfficerSSale−5.00K$30.53−$152.6K−4.8%99.5K after2 lots10b5-1
Aug 3, 2023 (view filing)Aug 1-22 daysKelsey Stephen MichaelSee RemarksSSale−33.3K$30.80−$1.03M−10.2%292.4K after2 lots10b5-1
Aug 1, 2023 (view filing)Jul 311 dayCislini JeffGeneral CounselSSale−1.50K$26.02−$39.0K−3.4%43.2K after10b5-1
Jun 22, 2023 (view filing)Jun 202 daysKelsey Stephen MichaelSee RemarksSSale−2.10K$24.89−$52.3K−0.6%325.8K after
Jun 22, 2023 (view filing)Jun 202 daysHorn Margaret AChief Operating OfficerSSale−2.10K$24.89−$52.3K−2.1%99.5K after
Jun 22, 2023 (view filing)Jun 202 daysAnders JackChief Financial OfficerSSale−1.25K$24.89−$31.1K−2.2%55.1K after
Jun 22, 2023 (view filing)Jun 202 daysCislini JeffGeneral CounselSSale−1.24K$25.14−$31.1K−2.7%44.7K after
Mar 21, 2023 (view filing)Mar 174 daysHorn Margaret ASee RemarksSSale−1.23K$21.78−$26.8K−1.2%100.1K after
Mar 21, 2023 (view filing)Mar 174 daysAnders JackChief Financial OfficerSSale−665$21.78−$14.5K−1.2%55.2K after
Mar 21, 2023 (view filing)Mar 174 daysKelsey Stephen MichaelSee RemarksSSale−1.23K$21.78−$26.8K−0.4%326.4K after
Mar 21, 2023 (view filing)Mar 174 daysWang XiaolinSee RemarksSSale−714$21.78−$15.6K−1.2%58.8K after
Mar 10, 2023 (view filing)Mar 7-103 daysLateSchroeder ThiloDirectorPPurchase+650.0K$21.76+$14.1M+72.0%1.55M after4 lots
Dec 21, 2022 (view filing)Dec 192 daysAnders JackChief Financial OfficerSSale−658$22.94−$15.1K−2.2%29.3K after
Dec 21, 2022 (view filing)Dec 192 daysWang XiaolinSee RemarksSSale−708$22.94−$16.2K−2.3%30.5K after
Dec 21, 2022 (view filing)Dec 192 daysKelsey Stephen MichaelSee RemarksSSale−1.22K$22.94−$28.0K−0.4%287.6K after
Dec 21, 2022 (view filing)Dec 192 daysHorn Margaret ASee RemarksSSale−1.22K$22.94−$28.0K−2.0%61.3K after
Nov 9, 2022 (view filing)Nov 72 daysHorn Margaret AChief Operating OfficerSSale−17.8K$20.15−$358.0K−100.0%0 after
Nov 2, 2022 (view filing)Oct 312 daysHorn Margaret AChief Operating OfficerSSale−17.8K$20.41−$362.6K−50.0%17.8K after
Oct 28, 2022 (view filing)Oct 262 daysHorn Margaret ASee RemarksSSale−17.8K$20.15−$358.0K−33.3%35.5K after
Sep 21, 2022 (view filing)Sep 192 daysWang XiaolinSee RemarksSSale−735$19.04−$14.0K−2.3%31.2K after
Sep 21, 2022 (view filing)Sep 192 daysKelsey Stephen MichaelSee RemarksSSale−1.27K$19.04−$24.1K−0.4%288.8K after
Sep 21, 2022 (view filing)Sep 192 daysHorn Margaret ASee RemarksSSale−1.27K$19.04−$24.1K−2.0%62.5K after
Sep 21, 2022 (view filing)Sep 192 daysAnders JackChief Financial OfficerSSale−449$19.04−$8.55K−1.5%30.0K after
Jul 26, 2022 (view filing)Jul 224 daysSchroeder ThiloDirectorPPurchase+250.0K$20.00+$5.00M+25.7%1.22M after
Jul 25, 2022 (view filing)Jul 223 daysKim Lorence H.DirectorPPurchase+50.0K$20.00+$1.00M+476.2%60.5K after
Jun 22, 2022 (view filing)Jun 175 daysWang XiaolinSee RemarksSSale−665$17.75−$11.8K−2.0%32.0K after
Jun 22, 2022 (view filing)Jun 175 daysKelsey Stephen MichaelSee RemarksSSale−1.15K$17.75−$20.3K−0.4%290.1K after
Jun 22, 2022 (view filing)Jun 175 daysHorn Margaret ASee RemarksSSale−1.15K$17.75−$20.3K−1.8%63.8K after
Jun 22, 2022 (view filing)Jun 175 daysAnders JackSee RemarksSSale−406$17.75−$7.21K−2.0%20.4K after
Jun 10, 2022 (view filing)7:07 PM ETJun 82 daysTepper Robert I and 3 others10% OwnerSSale−419.9K$20.25−$8.50M−7.6%5.10M after
Jun 10, 2022 (view filing)Jun 82 daysExter NeilDirectorSSale0–$0–0 after
Mar 29, 2022 (view filing)Mar 25-284 daysSchroeder ThiloDirectorPPurchase+42.7K$24.79+$1.06M+4.6%971.3K after3 lots
Mar 24, 2022 (view filing)Mar 22-242 daysSchroeder ThiloDirectorPPurchase+232.4K$23.63+$5.49M+33.4%928.6K after6 lots
Mar 21, 2022 (view filing)Mar 174 daysHorn Margaret ASee RemarksSSale−321$18.61−$5.97K−0.5%64.0K after
Mar 21, 2022 (view filing)Mar 174 daysKelsey Stephen MichaelSee RemarksSSale−321$18.62−$5.98K−0.1%290.3K after
Mar 21, 2022 (view filing)Mar 174 daysWang XiaolinSee RemarksSSale−240$18.61−$4.47K−0.8%31.7K after
Mar 21, 2022 (view filing)Mar 174 daysGoldsmith Mark ASee RemarksSSale−1.02K$18.61−$19.0K−0.5%185.6K after
Mar 21, 2022 (view filing)Mar 174 daysAnders JackSee RemarksSSale−159$18.62−$2.96K−0.8%19.9K after
Mar 21, 2022 (view filing)Mar 17-214 daysSchroeder ThiloDirectorPPurchase+168.1K$20.40+$3.43M+31.8%696.2K after5 lots
Mar 14, 2022 (view filing)Mar 10-114 daysSchroeder ThiloDirectorPPurchase+43.5K$20.63+$897.8K+9.0%528.2K after3 lots
Mar 9, 2022 (view filing)Mar 7-92 daysSchroeder ThiloDirectorPPurchase+246.4K$18.91+$4.66M+103.4%484.7K after6 lots